Targeting influenza vaccine antigens to antigen presenting cells
Lead Research Organisation:
THE PIRBRIGHT INSTITUTE
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
The generation of protective immune responses as early as possible in the life of the perinatal bird is a critical practical issue as pathogen challenge may occur at hatch. The targeting of vaccine antigens to dendritic cells (DC) may be used to provoke stronger and faster immune responses than are achieved with conventional vaccines. This project will seek to produce sterile immunity to avian viruses in hatchling chickens. Approaches reported in the mammalian literature include targeting specific DC cell surface molecules with either constructs of antigen-DC ligand or with specifically modified recombinant vaccine viruses. These approaches have not been reported in poultry, partly due to a lack of appropriate APC-specific reagents. The recent cloning of APC-specific molecules have now provided the tools both for targeting and the subsequent analysis of immune responses. We will initially target CD40, a costimulatory molecule cloned in John Young’s lab, and DEC 205 an endocytosis receptor cloned in this lab. This project will apply these strategies to the potentiation of vaccination against avian influenza virus (AIV). Targetting molecules will include both monoclonal antibodies and fusion proteins. These will be linked with relevant avian influenza virus antigens, and used to vaccinate chicks. Cellular and humoral immune responses will be measured and chicks challenged with low and high pathogenicity avian influenza virus.
Modification of vaccines viruses better to target DCs will be explored in collaboration with Adrian Hill’s group at Oxford. Recombinant adenovirus will be produced to include AIV genes and will utilise DC ligands to enhance the transduction of chicken DCs in vivo. It is anticipated that this project will provide data that will be used in further grant applications and approaches to industrial partners.
Modification of vaccines viruses better to target DCs will be explored in collaboration with Adrian Hill’s group at Oxford. Recombinant adenovirus will be produced to include AIV genes and will utilise DC ligands to enhance the transduction of chicken DCs in vivo. It is anticipated that this project will provide data that will be used in further grant applications and approaches to industrial partners.
Planned Impact
unavailable
Organisations
People |
ORCID iD |
| Colin Butter (Principal Investigator) |
Publications
Chappell P
(2015)
Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding.
in eLife
Ciccone NA
(2014)
A B-cell targeting virus disrupts potentially protective genomic methylation patterns in lymphoid tissue by increasing global 5-hydroxymethylcytosine levels.
in Veterinary research
Mullarkey C
(2013)
Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA-NP+M 1 coadministration with inactivated influenza vaccine
in European Journal of Immunology
Parker A
(2012)
Chicken class II DMA and DMB are similar to mammals, but a second DMB gene differs in expression level, regulation and structural features
in Molecular Immunology
Salomonsen J
(2014)
Sequence of a complete chicken BG haplotype shows dynamic expansion and contraction of two gene lineages with particular expression patterns.
in PLoS genetics
Smith J
(2015)
Analysis of the early immune response to infection by infectious bursal disease virus in chickens differing in their resistance to the disease.
in Journal of virology
Staines K
(2013)
Expression of chicken DEC205 reflects the unique structure and function of the avian immune system.
in PloS one
Staines K
(2014)
Evolution of an expanded mannose receptor gene family.
in PloS one
| Description | We have, for the first time, provided immunological tools to investigate antigen presenting cells within a bird. We have also designed a novel vaccine to protect chickens against avian influenza infection. |
| Exploitation Route | The development of further understanding and also of novel vaccines. |
| Sectors | Agriculture Food and Drink |
| Description | Our findings have been used in further study to understand the development of immune responses in avian species and also in the design of novel vaccines. |
| First Year Of Impact | 2012 |
| Sector | Agriculture, Food and Drink |
| Description | Interviews |
| Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | Many television and radio interviews in the area of avian influenza and particularly my research. Both national and local media. |
| Year(s) Of Engagement Activity | 2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018 |